Skip to content

YI

111, Inc.

NASDAQ · Healthcare · Medical - Pharmaceuticals · CN

$3.51
+5.26%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue11.3B12.2B14.4B14.9B13.5B
Cost of Revenue10.7B11.5B13.6B14.1B12.7B
Gross Profit652.0M703.7M829.2M849.0M840.0M
Operating Expenses
R&D Expense
SG&A Expense384.4M655.0M384.8M672.6M663.5M
General & Admin Expense60.3M58.7M70.9M224.2M205.6M
Selling & Marketing Expense324.1M596.2M313.9M448.4M457.9M
Other Expenses294.4M58.7M442.3M526.5M547.5M
Total Operating Expenses678.8M713.7M827.1M1.2B1.2B
Cost and Expenses11.4B12.2B14.4B15.3B13.9B
Operating Income (EBIT)(26.8M)(10.0M)2.1M(350.1M)(371.0M)
Non-Operating
Interest Income3.4M3.8M7.0M8.8M8.1M
Interest Expense34.5M34.6M28.3M20.1M13.4M
Net Interest Income(31.2M)(30.8M)(21.3M)(11.3M)(5.3M)
Other Non-Op Income/Expense(15.1M)(11.9M)(22.8M)(3.1M)(5.1M)
Non-Operating Income (excl Interest)(15.2M)(5.5M)(17.1M)(8.4M)
EBT (Pre-Tax Income)(41.9M)(21.9M)(20.7M)(353.2M)(376.1M)
Income Tax Expense(3.0K)12.6K96.0K251.0K
Bottom Line
Net Income(75.4M)(16.8M)(64.7M)(392.7M)(416.9M)
Earnings from Cont. Ops(41.9M)(21.9M)(20.8M)(353.4M)(376.1M)
Earnings from Discont. Ops
Bottom Line Net Income(85.6M)(64.6M)(64.7M)(392.7M)(416.9M)
Per Share
Basic EPS($9.76)($7.42)($7.52)($46.58)($50.04)
Diluted EPS($9.76)($7.42)($7.52)($46.58)($50.04)
Revenue Per Share$1,290.45$1,403.69$1,671.18$1,773.11$1,622.32
Shares
Basic Shares Outstanding8.8M8.7M8.6M8.4M8.3M
Diluted Shares Outstanding8.8M8.7M8.6M8.4M8.3M
Profitability Metrics
EBITDA(16.8M)1.8M24.6M(311.3M)(321.8M)
D&A11.8M17.0M21.8M40.8M
EBIT(16.8M)(10.0M)7.7M(333.0M)(362.6M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026